John P. Longenecker Ph.D., Director at Pacira BioSciences, Inc. (PCRX), sold 14,000 shares at $71.74 ($1.0M) on 2022-03-03, disclosed to the SEC on 2022-03-07.
Open-market sale of $1.0M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.74 | 7,000 | $502K | 50.0% |
| 2 | $71.74 | 7,000 | $502K | 50.0% |
| Total | $71.74 avg | 14,000 | $1.0M | 100% |
| Filing → |
| ALRN | BUY | 2018-08-14 | $25K | — | Filing → |
| PCRX | BUY | 2016-01-14 | $20K | — | Filing → |
| PCRX | SELL | 2015-03-16 | $286K | — | Filing → |